(Q48153941)

9 February 2018

title

Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure (English)

1 reference

9 February 2018

Patricia S. Goldman-Rakic

author

series ordinal

3

object named as

Goldman-Rakic PS

1 reference

9 February 2018

Selemon LD

1

1 reference

9 February 2018

Lidow MS

series ordinal

2

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

published in

Biological Psychiatry

1 reference

9 February 2018

volume

46

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

161-172

1 reference

9 February 2018

A case report of risperidone-induced obsessive-compulsive symptoms

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Quantitative light microscopic demonstration of increased pallidal and striatal met5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol but not with clozapine: implications for the pathogenesis of neuroleptic-induc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

The effects of haloperidol on synaptic patterns in the rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Mu and delta opiate receptors in neuronal and astroglial primary cultures from various regions of the brain--coupling with adenylate cyclase, localisation on the same neurones and association with dopamine (D1) receptor adenylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Glutamate in schizophrenics and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

An intricately patterned prefronto-caudate projection in the rhesus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Possible relationship between glial cells, dopamine and the effects of antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

The effect of chronic haloperidol treatment on dendritic spines in the rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Changes in caudate volume with neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Cerebral Glutamate, Neuroleptic Drugs and Schizophrenia: Increase of Cerebrospinal Fluid Glutamate Levels and Decrease of Striate Body Glutamate Levels following Sulpiride Treatment in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Dopaminergic regulation of cerebral cortical microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

The cerebral cortex: a case for a common site of action of antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Antipsychotic drug effects on glutamatergic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Changes in single symptoms and separate factors of the schizophrenic syndrome after treatment with risperidone or haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Duration of psychosis and outcome in first-episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Risperidone in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Haloperidol-induced morphological changes in striatum are associated with glutamate synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Glial reduction in the subgenual prefrontal cortex in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Synaptic efficacy enhanced by glial cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Localization of neuronal and glial glutamate transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Antipsychotic drug doses and neuroleptic/dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Haloperidol pharmacokinetics: A preliminary study in rhesus monkeys using a new radioimmunoassay procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Neuropathology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Frontal abnormalities in a patient with obsessive-compulsive disorder: the role of structural lesions in obsessive-compulsive behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Inhibitory effects of bromocriptine on vascular smooth muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

Schizophrenia and glutamatergic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900113-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00113-4

1 reference

9 February 2018

1 reference

9 February 2018